Literature DB >> 7400283

Specific high-performance liquid chromatographic method for estimation of the cis(Z)- and trans(E)-isomers of clopenthixol and a N-dealkyl metabolite.

T Aaes-Jørgensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7400283     DOI： 10.1016/s0378-4347(00)81700-4

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  10 in total

1.  Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.

Authors:  A Viala; B Ba; A Durand; F Gouezo; N Hou; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 2.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

3.  Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients.

Authors:  I Matheson; J Skjaeraasen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Zuclopenthixol decanoate in schizophrenia: serum levels and clinical state.

Authors:  A Jørgensen; T Aaes-Jørgensen; A Gravem; K F Amthor; S J Dencker; I Rosell; P C Baastrup; J Buckhave; L F Gram
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 5.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

6.  Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo.

Authors:  T Aaes-Jørgensen; L Kirk; E Petersen; P Danneskiold-Samsøe; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.

Authors:  K Kistrup; J Gerlach; T Aaes-Jørgensen; N E Larsen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo.

Authors:  A Amdisen; T Aaes-Jørgensen; N J Thomsen; V T Madsen; M S Nielsen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

9.  Zuclopenthixol levels in serum and breast milk.

Authors:  T Aaes-Jørgensen; F Bjørndal; U Bartels
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

10.  Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia-a systematic review of the literature.

Authors:  Loren Bailey; David Taylor
Journal:  Psychopharmacology (Berl)       Date:  2019-07-12       Impact factor: 4.530
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.